1. Klaassen, C. D.; O’Brien, C. P. In Goodman & Gilman’s The Pharmacological Basis of Therapeutics; Hardman, J. G.; Limbird, L. E.; Molinoff, P. B.; Ruddon, R. W., eds.; McGrawn-Hill: New York, 1996, Ch. 4, p. 63, and Chapter 24, p 557.
2. Pearson, J. In An Introduction to Neurotransmission in Health and Disease; Riederer, P., Kopp, N., Pearson, J., eds.; University Press: Oxford, 1990; Chapters 21 and 26.
3. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity
4. The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: Evidence for the protective effect of chlormethiazole